Nuclea, IRCM Partner to Validate Mass Spec Diabetes Assays

News   Aug 12, 2015

 
Nuclea, IRCM Partner to Validate Mass Spec Diabetes Assays
 
 
 

RELATED ARTICLES

SCIEX Announces Joint Venture with Zhenjang Dian Diagnostics in China

News

Leading diagnostics companies combine to address diagnostic and wellness testing in China.

READ MORE

Fracking Environmental Contaminants Pregnancy Risk

News

Scientists studying the concentration of muconic acid in pregnant women have found elevated levels in those from areas where fracking is concurring. Muconic acid is a degradation product of benzene, a volatile, toxic and carcinogenic compound linked to natural gas extraction known to cause birth defects.

READ MORE

Heart Test Safe for Global Use

News

A blood test that spots whether people are at risk of a heart attack could improve the treatment of people with chest pain at emergency departments around the world, a study suggests.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE